News & Events

Keep up to date with the latest news and check out where our team will be headed this event season.

Join us! World Vaccine Congress | 3-6 April 2023 | Washington DC

Location: Walter E. Washington Convention Center

Date: 04/03/2023 - 04/06/2023

Vibalogics and Recipharm will be attending World Vaccine Congress 2023 together. The World Vaccine Congress is the largest, most established m…

Join us! DCAT Week | 20-23 March 2023 | New York City

Location: New York City

Date: 03/20/2023 - 03/23/2023

Vibalogics, Recipharm, Arranta and Genibet will be attending DCAT Week 2023. DCAT Week is the premiere event for the global bio/pharmaceutical…

Join us! Advanced Therapies | 14– 15 March 2023 | London

Location: ExCeL, London

Date: 03/14/2023 - 03/15/2023

Vibalogics and Recipharm will be attending Advanced Therapies 2023. The Advanced Therapies Congress is Europe’s largest cell and gene therapy …

Vibalogics Bolsters Scientific Advisory Board with Two Ne…

Vibalogics, a global contract development and manufacturing organization (CDMO) and leader in the virotherapy services market has announced tw…

Recipharm AB Closes Acquisition of Vibalogics

Recipharm AB Closes Acquisition of Vibalogics Vibalogics, a contract development and manufacturing organization (CDMO) focused on the manufac…

Vibalogics Completes Major Milestone in $50M Cuxhaven Fac…

Vibalogics' expansion will provide added capacity and scalable clinical solutions for virotherapy manufacturing Vibalogics, a leading vir…

Load more

Process Development

Full development services are offered to transfer and mature processes for optimized scale, productivity, product profile and cost of goods.

Analytical Development

Method development and transfer services span characterization and quality control assays for identity, purity, potency, titer, and safety.

QC Release & Stability Testing

In-house quality control and stability services ensure timely testing of bulk, in-process control, and final drug product.

Oncolytic Virus

Specialist in the manufacture of replication competent engineered and wild-type oncolytic viruses, with a deep track record you can trust.

Gene Therapy

Expertise across gene therapy vectors produced by transient, helper-virus, and stable producer cell lines minimize time-to-market.

Vaccines

Scalable capacity and effective cost of goods management for vaccine product development and manufacture.